- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/56 - Nitrogen atoms
Patent holdings for IPC class C07D 211/56
Total number of patents in this class: 313
10-year publication summary
|
13
|
29
|
23
|
15
|
21
|
15
|
18
|
12
|
14
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2708 |
20 |
| ChemoCentryx, Inc. | 386 |
8 |
| ADT Pharmaceuticals, LLC | 13 |
8 |
| Cytokinetics, Inc. | 279 |
7 |
| Bristol-myers Squibb Company | 4880 |
6 |
| Sumitomo Chemical Company, Limited | 9043 |
6 |
| Amicus Therapeutics, Inc. | 351 |
6 |
| Araxes Pharma LLC | 92 |
6 |
| Mission Therapeutics Limited | 80 |
6 |
| Janssen Pharmaceutica N.V. | 3394 |
5 |
| ACADIA Pharmaceuticals Inc. | 206 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 875 |
5 |
| Unichem Laboratories Limited | 102 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
4 |
| Sanofi | 4072 |
4 |
| Rappta Therapeutics Oy | 9 |
4 |
| Centre National de La Recherche Scientifique | 10464 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
3 |
| Kaneka Corporation | 4534 |
3 |
| Other owners | 194 |